SCHEMBL4186785

SCHEMBL4186785

NCC(O)CC(=O)N1CCOCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.48
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
POLB P06746 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
GAA P10253 1/20 0.45
TSHR P16473 2/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TP53 P04637 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
GABRR1 P24046 2/20 0.42
LMNA P02545 2/20 0.42
GLA P06280 1/20 0.40
USP2 O75604 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA9 Q16790 1/20 0.39
FKBP1A P62942 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4198386 0.82 L3MBTL1 (0.42) L3MBTL1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL8488474 0.81 L3MBTL1 (0.48) L3MBTL1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL4198380 0.81 L3MBTL1 (0.44) L3MBTL1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL3818013 0.80 L3MBTL1 (0.55) L3MBTL1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL4186778 0.78 L3MBTL1 (0.48) L3MBTL1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL5113390 0.78 GABRR1 (0.42) L3MBTL1KMT2APOLBSMN1; SMN2GABRR1
SCHEMBL4399683 0.77 L3MBTL1 (0.49) L3MBTL1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL8484573 0.77 L3MBTL1 (0.52) L3MBTL1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL1303142 0.76 L3MBTL1 (0.59) L3MBTL1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL3988865 0.76 L3MBTL1 (0.50) L3MBTL1MEN1KMT2APOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1686987-A4 ADVANCED INDOLINONE BASED PROTEIN KINASE INHIBITORS SCRIPPS RESEARCH INST (US) 2009-02-25 EP disclosed
US-20080044881-A1 Advanced Indolinone Based Protein Kinase Inhibitors SCRIPPS RESEARCH INSTITUTE, THE 2008-02-21 US disclosed
US-20080044881-A1 Advanced Indolinone Based Protein Kinase Inhibitors SCRIPPS RESEARCH INSTITUTE, THE 2008-02-21 US disclosed
US-20060287381-A1 Enhanced indolinone based protein kinase inhibitors THE SCRIPPS RESEARCH INSTITUTE (US) 2006-12-21 US disclosed
EP-1686987-A2 ADVANCED INDOLINONE BASED PROTEIN KINASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2006-08-09 EP disclosed
WO-2005053614-A2 ADVANCED INDOLINONE BASED PROTEIN KINASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2005-06-16 WO disclosed
WO-2005053686-A1 INDOLINONE BASED PROTEIN KINASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287381-A1 Enhanced indolinone based protein kinase inhibitors PHKG1, PHKG2, PRKCH L3MBTL1 2815/4885MEN1 4665/4885KMT2A 1643/4885
US-20080044881-A1 Advanced Indolinone Based Protein Kinase Inhibitors PHKG1, PHKG2, HIPK1 L3MBTL1 1974/4885MEN1 4193/4885KMT2A 2098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.